![Chris Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Chris Anderson currently works at DICE Therapeutics, Inc., as Secretary from 2023, Sigilon Therapeutics, Inc., as Secretary from 2023, and POINT Biopharma Global, Inc., as Secretary from 2023.
Cargos activos de Chris Anderson
| Empresas | Cargo | Inicio |
|---|---|---|
| DICE THER | Secretario Corporativo | 09/08/2023 |
| SIGILON THERAPEUTICS, INC. | Secretario Corporativo | 11/08/2023 |
| POIT BIOP | Director/Miembro de la Junta | 27/12/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Chris Anderson
